Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Benesch, M; Deeg, HJ; Wells, D; Loken, M.
Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes.
Hematology. 2004; 9(3): 171-177.
Doi: 10.1080/10245330410001701521
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Benesch Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The Myelodysplastic Syndrome (MDS) comprises a spectrum of hematopoietic stem cell disorders. Identification of additional parameters that might distinguish different risk groups or entities would be useful. Flow cytometric studies have begun to characterize individual or composite immunophenotypic abnormalities as well as light scatter properties that may be helpful for diagnosis and of prognostic value for the natural course of the disease and for outcome after therapy. Here we review the current state of the art of the use of flow cytometry in patients with MDS.
- Find related publications in this database (using NLM MeSH Indexing)
- Flow Cytometry - methods
- Humans - methods
- Immunophenotyping - methods
- Myelodysplastic Syndromes - classification
- Risk Assessment - classification